FDA inspection
GlaxoSmithKline LLC: FDA inspection ending Dec 16, 1999
FDA inspection 7108 · Voluntary Action Indicated (VAI) · Research Triangle Park, NC
Key facts
| Inspection ID | 7108 |
|---|---|
| Firm | GlaxoSmithKline LLC |
| FEI number | 1035048 |
| Address | 5 Moore Dr |
| City | Research Triangle Park |
| State | NC |
| ZIP | 27709 |
| Fiscal year | 2000 |
| Inspection end date | Dec 16, 1999 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data